Exact Sciences Corp (NAS:EXAS)
$ 54.21 -0.51 (-0.93%) Market Cap: 10.03 Bil Enterprise Value: 11.77 Bil PE Ratio: 0 PB Ratio: 3.12 GF Score: 80/100

Exact Sciences Corp at Jefferies Healthcare Conference Transcript

Jun 08, 2022 / 05:00PM GMT
Release Date Price: $49.49 (+2.89%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

(technical difficulty)

[A few things].

Everett V. Cunningham
Exact Sciences Corporation - Chief Commercial Officer

Yes. Thanks, Bran. And like Jeff said, we're happy to be here. I joined Exact in the fall of 2021. I always tell people that I'm not new to health care. I've been in health care for 31 years. I spent my first 21 years at Pfizer Pharmaceutical in various roles, sales, marketing. I actually spent a couple of years in human resources, actually, at Pfizer, then went on to work at Quest Diagnostics in the Chief Commercial Officer role, spent 7 years at Quest Diagnostics. And then just my last 2 years before Exact has been at GE Healthcare, running their U.S. and Canada business.

The reason I came to Exact is just because of the mission, of eradicating cancer. When you think of cancer, the impact that it has in individuals, families, friends, there couldn't be, in my opinion, be a more important place to be in health care. And then what Exact is doing, I'm sure you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot